Skip to content

Study · Randomized controlled trial · n = 6 · 1988

6 results

The effect of oxytocin infusion on adenohypophysial and adrenal cortical responses to insulin-induced hypoglycaemia.

Nussey SS, Page SR, Ang VT, Jenkins JS, White A

Clinical endocrinology1 Sept 1988Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study6

6 results from studies that gave the peptide. 6 results from people.

  1. 01HumanRandomized controlled trialPharmacokinetics

    In six lean men, mean plasma oxytocin increased from 1.9 pmol/l to 138 pmol/l during oxytocin infusion.

    In plain wordsIn six lean men, oxytocin infusion raised blood oxytocin levels.

    Peptide
    Oxytocin
    Outcome
    IncreasePlasma oxytocin during oxytocin infusion
    Study

    n = 6

    Outcome group
    Pharmacokinetics · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Mean plasma oxytocin before infusion
    1.9 pmol/l
    oxytocin infusion
    Mean plasma oxytocin during infusion
    138 pmol/l
    oxytocin infusion

    Source sentences

    Summary
    During the oxytocin infusion mean plasma oxytocin increased from 1.9 pmol/l to 138 pmol/l.
    1 context sentence
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.
  2. 02HumanRandomized controlled trialEfficacy outcome

    In six lean men, the blood sugar nadir during insulin-induced hypoglycaemia did not differ significantly between oxytocin and saline infusion.

    In plain wordsIn six lean men, the lowest blood sugar after insulin was not different with oxytocin than with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changeBlood sugar nadir during insulin-induced hypoglycaemia
    Study

    n = 6

    Comparator
    Saline infusion
    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Blood sugar nadir occurred at the onset of symptoms (time S) with no significant differences between oxytocin and saline infusion.
    1 context sentence
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.
  3. 03HumanRandomized controlled trialEfficacy outcome

    In six lean men, peak plasma ACTH after insulin-induced hypoglycaemia did not differ significantly between oxytocin and saline infusion.

    In plain wordsIn six lean men, oxytocin infusion did not change the peak ACTH stress-hormone response to low blood sugar compared with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changePeak plasma ACTH response to hypoglycaemia
    Study

    n = 6

    Comparator
    Saline infusion
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Peak plasma ACTH
    266 ng/l
    oxytocin
    Peak plasma ACTH
    281 ng/l
    saline

    Source sentences

    Summary
    There were no significant differences in plasma concentrations of ACTH, cortisol, GH or prolactin between saline and oxytocin infusion.
    2 context sentences
    Summary · context
    Peak increase in plasma ACTH (oxytocin 266 +/- 54 ng/l; saline 281 +/- 43 ng/l, mean +/- SEM)
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.
  4. 04HumanRandomized controlled trialEfficacy outcome

    In six lean men, peak plasma cortisol after insulin-induced hypoglycaemia did not differ significantly between oxytocin and saline infusion.

    In plain wordsIn six lean men, oxytocin infusion did not change the peak cortisol response to low blood sugar compared with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changePeak plasma cortisol response to hypoglycaemia
    Study

    n = 6

    Comparator
    Saline infusion
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Peak plasma cortisol
    680 nmol/l
    oxytocin
    Peak plasma cortisol
    656 nmol/l
    saline

    Source sentences

    Summary
    There were no significant differences in plasma concentrations of ACTH, cortisol, GH or prolactin between saline and oxytocin infusion.
    2 context sentences
    Summary · context
    peak plasma cortisol (oxytocin 680 +/- 47 nmol/l: saline 656 +/- 40 nmol/l)
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.
  5. 05HumanRandomized controlled trialEfficacy outcome

    In six lean men, peak plasma growth hormone after insulin-induced hypoglycaemia did not differ significantly between oxytocin and saline infusion.

    In plain wordsIn six lean men, oxytocin infusion did not change the peak growth hormone response to low blood sugar compared with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changePeak plasma growth hormone response to hypoglycaemia
    Study

    n = 6

    Comparator
    Saline infusion
    Outcome group
    Growth hormone and IGF-1 · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Peak plasma GH
    96 mU/l
    oxytocin
    Peak plasma GH
    106 mU/l
    saline

    Source sentences

    Summary
    There were no significant differences in plasma concentrations of ACTH, cortisol, GH or prolactin between saline and oxytocin infusion.
    2 context sentences
    Summary · context
    peak GH (oxytocin 96 +/- 17.8 mU/l; saline 106 +/- 18.6 mU/l)
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.
  6. 06HumanRandomized controlled trialEfficacy outcome

    In six lean men, peak plasma prolactin after insulin-induced hypoglycaemia did not differ significantly between oxytocin and saline infusion.

    In plain wordsIn six lean men, oxytocin infusion did not change the peak prolactin response to low blood sugar compared with saline.

    Peptide
    Oxytocin
    Outcome
    No significant changePeak plasma prolactin response to hypoglycaemia
    Study

    n = 6

    Comparator
    Saline infusion
    Outcome group
    Pituitary hormones · Endocrine and hormones
    Studied dose
    Dose not stated

    Measurements

    Peak plasma prolactin
    1332 mU/l
    oxytocin
    Peak plasma prolactin
    1242 mU/l
    saline

    Source sentences

    Summary
    There were no significant differences in plasma concentrations of ACTH, cortisol, GH or prolactin between saline and oxytocin infusion.
    2 context sentences
    Summary · context
    prolactin (oxytocin 1332 +/- 239 mU/l; saline 1242 +/- 273 mU/l)
    Summary · context
    The responses of plasma adrenocorticotrophin (ACTH), cortisol, growth hormone (GH) and prolactin to insulin-induced hypoglycaemia were studied in six lean male subjects (age 22-29 years). Intravenous insulin tests were performed with and without oxytocin infusion.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:52 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.